Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

11.57

+0.40 (3.58%)

Jul 31, 2025, 12:38 PM - Market open

Anavex Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2016 - 2020
Market Capitalization	988	482	537	804	1,359	274	Upgrade
Market Cap Growth	74.63%	-10.27%	-33.27%	-40.83%	396.34%	64.61%	Upgrade
Enterprise Value	851	343	382	651	1,202	246	Upgrade
Last Close Price	11.17	5.68	6.55	10.32	17.95	4.55	Upgrade
PB Ratio	9.55	4.01	3.78	5.65	9.01	10.06	Upgrade
P/TBV Ratio	9.69	4.01	3.78	5.65	9.01	10.06	Upgrade
Quick Ratio	6.70	8.80	12.27	14.92	14.93	4.67	Upgrade
Current Ratio	6.74	8.86	12.32	14.95	14.97	4.73	Upgrade
Return on Equity (ROE)	-40.17%	-32.81%	-33.41%	-32.71%	-42.58%	-110.59%	Upgrade
Return on Assets (ROA)	-25.44%	-21.81%	-21.59%	-18.95%	-23.87%	-55.77%	Upgrade
Return on Capital (ROIC)	-28.36%	-24.12%	-23.32%	-20.31%	-26.29%	-70.26%	Upgrade
Earnings Yield	-4.88%	-8.93%	-8.85%	-5.96%	-2.79%	-9.60%	Upgrade
FCF Yield	-3.08%	-6.40%	-5.18%	-3.01%	-2.23%	-7.77%	Upgrade
Buyback Yield / Dilution	-3.60%	-4.61%	-3.74%	-10.18%	-19.95%	-18.99%	Upgrade

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q